Teladoc (TDOC) Reports Q4 Loss of $0.76, Slight Beat on Revenues; Offers FY18 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- Intel shares fall as competitor reports record results
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Teladoc (TDOC) Reports Expanded Collaboration with Microsoft (MSFT)
March 1, 2018 4:43 PM ESTTeladoc, Inc. (NYSE: TDOC) announced today its expanded collaboration with Microsoft (NYSE: MSFT). The organizations will be working together to advance the delivery of telehealth, with Teladocs platform running on the Microsoft Azure cloud platform. As a result of the joint go-to-market strategy, hospitals and health systems across the U.S. will have greater access to... More
Teladoc (TDOC) PT Lowered to $47 at Chardan Capital Markets, Keeps 'Buy'
February 28, 2018 7:29 AM ESTChardan Capital Markets lowered its price target on Teladoc (NYSE: TDOC) to $47.00 (from $48.00) while maintaining a Buy rating.
Analyst Steven Wardell commented, "After market close on Tue., TDOC reported earnings in-line with Consensus and maintained its preliminary 2018 revenue and adjusted EBITDA estimate... More
Teladoc (TDOC) PT Raised to $43 at Cowen; Sees Potential Upside to 2018 Guide
February 28, 2018 6:46 AM ESTCowen raised its price target on Teladoc (NYSE: TDOC) to $43.00 (from $39.00) while maintaining an Outperform rating following results.
Analyst Charles Rhyee sees potential upside to 2018 guidance.
... More


